Literature DB >> 27026020

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.

Glenn N Levine1, Eric R Bates1, John A Bittl1, Ralph G Brindis1, Stephan D Fihn1, Lee A Fleisher1, Christopher B Granger1, Richard A Lange1, Michael J Mack1, Laura Mauri1, Roxana Mehran1, Debabrata Mukherjee1, L Kristin Newby1, Patrick T O'Gara1, Marc S Sabatine1, Peter K Smith1, Sidney C Smith1.   

Abstract

Entities:  

Keywords:  AHA Scientific Statements; P2Y12 inhibitor; acute coronary syndrome; aspirin; coronary artery disease; coronary stents; dual antiplatelet therapy (DAPT); focused update; stable ischemic heart disease

Mesh：

Substances：

Year:  2016        PMID： 27026020     DOI： 10.1161/CIR.0000000000000404

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  282 in total

Review 1.  Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease.

Authors:  Sehrish Ali; Natasha Dave; Salim S Virani; Sankar D Navaneethan
Journal:  Curr Atheroscler Rep       Date:  2019-06-22       Impact factor: 5.113

2.  Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016.

Authors:  Elias J Dayoub; Matthew Seigerman; Sony Tuteja; Taisei Kobayashi; Daniel M Kolansky; Jay Giri; Peter W Groeneveld
Journal:  JAMA Intern Med       Date:  2018-07-01       Impact factor: 21.873

3.  Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes.

Authors:  Alexander C Fanaroff; Derek Cyr; Megan L Neely; Jeffery Bakal; Harvey D White; Keith A A Fox; Paul W Armstrong; Renato D Lopes; E Magnus Ohman; Matthew T Roe
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-12

4.  Long-term dual antiplatelet therapy and concomitant optimal medical therapy following percutaneous coronary intervention.

Authors:  Giuseppe Gargiulo; Marco Valgimigli
Journal:  Cardiovasc Diagn Ther       Date:  2017-06

5.  Comparison of ESC and ACC/AHA guidelines for myocardial revascularization: are the differences clinically relevant? The European perspective.

Authors:  Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2017-04-21       Impact factor: 5.952

Review 6.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

7.  Surgery after drug-eluting stent implantation: it's not all doom and gloom!

Authors:  Francesco Saia
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

8.  Use of Prasugrel and Ticagrelor in Stable Ischemic Heart Disease After Percutaneous Coronary Intervention, 2009-2016.

Authors:  Elias J Dayoub; Ashwin S Nathan; Sameed Ahmed M Khatana; Matthew Seigerman; Sony Tuteja; Taisei Kobayashi; Daniel M Kolansky; Peter W Groeneveld; Jay Giri
Journal:  Circ Cardiovasc Interv       Date:  2019-01       Impact factor: 6.546

9.  Prevalence of Chronic Kidney Disease, Thrombotic Cardiovascular Events, and Use of Oral P2Y12 Inhibitors among Veterans.

Authors:  Manisha Singh; Deepa Raghavan; James S Williams; Bradley C Martin; Teresa J Hudson; Richard R Owen; Nishank Jain
Journal:  Am J Nephrol       Date:  2018-02-01       Impact factor: 3.754

10.  Clopidogrel utilization in patients with coronary artery disease and diabetes mellitus: should we determine CYP2C19*2 genotype?

Authors:  Saoussen Chouchene; Rym Dabboubi; Haythem Raddaoui; Hela Abroug; Khaldoun Ben Hamda; Sondess Hadj Fredj; Fatma Abderrazak; Mayssa Gaaloul; Marwa Rezek; Fadoua Neffeti; Ilhem Hellara; Mouna Sassi; Linda Khefacha; Asma Sriha; Semir Nouira; Mohamed Fadhel Najjar; Faouzi Maatouk; Taieb Messaoud; Mohsen Hassine
Journal:  Eur J Clin Pharmacol       Date:  2018-08-03       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.